NL193441C - Farmaceutisch preparaat voor veterinair gebruik. - Google Patents
Farmaceutisch preparaat voor veterinair gebruik. Download PDFInfo
- Publication number
- NL193441C NL193441C NL8702188A NL8702188A NL193441C NL 193441 C NL193441 C NL 193441C NL 8702188 A NL8702188 A NL 8702188A NL 8702188 A NL8702188 A NL 8702188A NL 193441 C NL193441 C NL 193441C
- Authority
- NL
- Netherlands
- Prior art keywords
- taf
- pyrrolidone
- peg
- pharmaceutical preparation
- methyl
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 10
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 22
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 10
- 229960003053 thiamphenicol Drugs 0.000 claims description 8
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 9
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21695/86A IT1197481B (it) | 1986-09-15 | 1986-09-15 | Preparazione farmaceutica per uso veterinario |
| IT2169586 | 1986-09-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8702188A NL8702188A (nl) | 1988-04-05 |
| NL193441B NL193441B (nl) | 1999-07-01 |
| NL193441C true NL193441C (nl) | 1999-11-02 |
Family
ID=11185526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8702188A NL193441C (nl) | 1986-09-15 | 1987-09-15 | Farmaceutisch preparaat voor veterinair gebruik. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4912138A (ja) |
| JP (1) | JP2571390B2 (ja) |
| BE (1) | BE1000189A3 (ja) |
| DE (1) | DE3730957C2 (ja) |
| FR (1) | FR2603803B1 (ja) |
| GB (1) | GB2195082B (ja) |
| IT (1) | IT1197481B (ja) |
| NL (1) | NL193441C (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1295369B1 (it) * | 1997-10-21 | 1999-05-12 | Fatro Spa | Composizione a base di tiamfenicolo e diclofenac |
| US20030153585A1 (en) * | 2000-01-13 | 2003-08-14 | Sven-Alexander Schreder | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
| ES2189682B1 (es) * | 2001-12-11 | 2004-04-01 | Laboratorios Del Dr. Esteve, S.A. | Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea. |
| PT1830885E (pt) * | 2004-12-21 | 2008-12-22 | Intervet Int Bv | Composição veterinária injectável |
| BRPI1002023A2 (pt) * | 2010-03-01 | 2011-10-25 | Nanocore Biotecnologia S A | forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3957994A (en) * | 1974-12-19 | 1976-05-18 | Nelson Research & Development Company | Topical anti-inflammatory composition and method of use |
| GB1538903A (en) * | 1975-04-11 | 1979-01-24 | Nelson Res & Dev | Carrier for a topically applied physiologically active agent or cosmetic agent |
| IL52533A (en) * | 1977-07-15 | 1980-01-31 | Abic Ltd | Injectable chloramphenicol composition |
| US4188402A (en) * | 1977-08-05 | 1980-02-12 | Clesa S.P.A. | Derivatives of the D-threo-1-phenyl-2-trifluoroacetamido-1,3-propandediol |
| DE2843963A1 (de) * | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin |
| US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
| IE49933B1 (en) * | 1979-07-05 | 1986-01-08 | Pfizer | Sulfonamide solutions |
| DE2952239A1 (de) * | 1979-12-22 | 1981-07-02 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Fungizide mischungen |
| US4361557A (en) * | 1980-01-28 | 1982-11-30 | Schering Corporation | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor |
| DE3209429A1 (de) * | 1982-03-16 | 1983-10-06 | Boehringer Ingelheim Vetmed | Mittel zur verbesserung der resorption von injizierten antibakteriell wirksamen substanzen und kombinationen, enthaltend ein benzyaminderivat |
| IT1212787B (it) * | 1983-11-03 | 1989-11-30 | Zambon Spa | Uso del tiamfenicolo o di un suo derivato per preparare composizioni farmaceutiche che inibiscono l'insorgere della tolleranza durante il trattamento di sindromi dolorose con analgesici centrali |
| US4575506A (en) * | 1983-11-03 | 1986-03-11 | Zambon S.P.A. | Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics |
-
1986
- 1986-09-15 IT IT21695/86A patent/IT1197481B/it active
-
1987
- 1987-09-10 GB GB8721313A patent/GB2195082B/en not_active Expired - Fee Related
- 1987-09-14 JP JP62230888A patent/JP2571390B2/ja not_active Expired - Lifetime
- 1987-09-14 US US07/095,673 patent/US4912138A/en not_active Expired - Fee Related
- 1987-09-14 BE BE8701030A patent/BE1000189A3/fr not_active IP Right Cessation
- 1987-09-15 NL NL8702188A patent/NL193441C/nl active Search and Examination
- 1987-09-15 FR FR878712752A patent/FR2603803B1/fr not_active Expired - Fee Related
- 1987-09-15 DE DE3730957A patent/DE3730957C2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3730957A1 (de) | 1988-03-17 |
| GB2195082A (en) | 1988-03-30 |
| JP2571390B2 (ja) | 1997-01-16 |
| FR2603803B1 (fr) | 1991-05-31 |
| NL8702188A (nl) | 1988-04-05 |
| NL193441B (nl) | 1999-07-01 |
| US4912138A (en) | 1990-03-27 |
| IT1197481B (it) | 1988-11-30 |
| BE1000189A3 (fr) | 1988-07-26 |
| GB2195082B (en) | 1990-03-28 |
| GB8721313D0 (en) | 1987-10-14 |
| FR2603803A1 (fr) | 1988-03-18 |
| IT8621695A0 (it) | 1986-09-15 |
| DE3730957C2 (de) | 1996-09-05 |
| JPS6383022A (ja) | 1988-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2298619T3 (es) | Granulados de meloxicam solubles en agua. | |
| US7396819B2 (en) | Anthelmintic formulations | |
| MXPA04007996A (es) | Composicion parasiticida de accion prolongada. | |
| EP0413538B1 (en) | Long active injectable formulations containing triacetin | |
| JPH08501317A (ja) | 抗菌性インターフェロン誘発性医薬品 | |
| JP2001506616A (ja) | 定温動物の寄生体の系統的なコントロールのための組成物 | |
| NL193441C (nl) | Farmaceutisch preparaat voor veterinair gebruik. | |
| US20050203034A1 (en) | Multi-action anthelmintic formulations | |
| KR101148501B1 (ko) | 엔로플록사신 미세캡슐 제형 및 그 제조 방법 | |
| US20060067954A1 (en) | Lipid stabilized formulations | |
| JP3890086B2 (ja) | 感染性下痢症予防及び治療用組成物 | |
| AU2015100768A4 (en) | Development of Doxycycline Injectable for Caged and Aviary Birds and there of | |
| US20060068020A1 (en) | Encapsulated pharmaceutical agents | |
| EP3265097A1 (en) | Compositions and methods for treatment and prevention of pyrexia in horses | |
| WO2005016356A1 (en) | Improved anthelmintic formulations | |
| KR100645268B1 (ko) | 동물약품용 약제학적 조성물 | |
| RU2168988C2 (ru) | Лекарственное средство для профилактики и лечения вирусных болезней животных | |
| JPS62236449A (ja) | 魚類餌料 | |
| US20160243146A1 (en) | LEVIA : A New Injectable Parasiticidal Veterinary Formulation of Levamisole HCl and Ivermectin Solution. | |
| RU2091074C1 (ru) | Эмульсия для лечения метритов крупного рогатого скота (варианты) | |
| RU2136173C1 (ru) | Кормовая добавка | |
| RU2105548C1 (ru) | Препарат "диарин" для лечения и профилактики желудочно-кишечных болезней молодняка животных | |
| US20220110896A1 (en) | Compositions and methods for providing sustained natural sleep | |
| RU2173143C2 (ru) | Способ пролонгированной химиопрофилактики пироплазмидозов овец и коз | |
| RU2170089C2 (ru) | Ветеринарный препарат с иммуномоделирующими свойствами |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| CNR | Transfer of rights (patent application after its laying open for public inspection) |
Free format text: FATRO S.P.A. |